Herman Steen

Herman Steen

Company: BiOrion Technologies

Job title: Co-Founder & Chief Executive Officer


Discussing Myofibroblast Membrane Receptors as Targets for PET-Imaging Tracers in Fibrosis & Fibrotic Cancer Stroma 8:30 am

Highlighting the translatability of fibrogenesis biomarkers across disease states Divulging the relevance of upregulated myofibroblast membrane receptors as sensitive fibrogenesis biomarkers to be used in PET-imaging of fibrogenesis in organ fibrosis and fibrotic cancer Proving early therapeutic effectiveness to give confidence taking the drug development forwardRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.